This indefinite delivery contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The $20 million single-award IDC is for research and development services and studies, with a period of performance through September 2028. Under this IDC, Eurofins has been issued two firm-fixed-price delivery orders. The first order, valued at $38,639.60, is for...
This indefinite delivery contract was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The $17,891,012 multiple-award contract, which runs through April 2025, is for CRO support services related to NCATS' medicinal chemistry program for lead optimization. The initial $1,000...
The federal contract IDV award is an Indefinite Delivery Contract with a ceiling value of $10,000,000 issued by the Food and Drug Administration (FDA) to the Lovelace Biomedical Research Institute, a non-profit contract research organization. The contract aims to procure preclinical research services and support the development of treatments and cures for various diseases and conditions, including respiratory diseases, HIV/AIDS, pain disorders, COVID-19 medical countermeasures, infectious...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. federal government, to In Vitro Strategies Limited Liability Company, a woman-owned small business. The contract has a total ceiling value of $187,438.64 and was set aside for small businesses. The purpose of this IDC is to provide in-vitro research and related services to support NIDA's mission. While the full scope of contracted work is not detailed, the...
This $49.9 million Indefinite Delivery Contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to PPD Development LP, a global contract research organization (CRO) subsidiary of Thermo Fisher Scientific. The contract is for research and development related to clinical studies under NIDA's Blueprint MedTech program, which focuses on medical technology development for nervous system disorders. Under this IDC, PPD will provide a range of services including developing...
The federal contract IDV award is for "PHARMACOLOGY STUDIES AND ANIMAL MODEL DEVELOPMENT AND RELATED SERVICES FOR DRUG DEVELOPMENT" and was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH). The multiple-award, indefinite delivery contract has a ceiling value of $48,882,666.00 and a period of performance through August 5, 2030. The prime contractor is Advanced Bioscience Laboratories, Inc....
The federal contract IDV award is a single-award Indefinite Delivery Contract issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Pharmacology Discovery Services Taiwan, LTD., a for-profit Taiwanese organization. The contract, valued up to $146.3M, supports NIAID's preclinical infectious disease research by providing a range of animal and animal replacement models for screening and evaluating candidate countermeasures such as therapeutics, vaccines,...
This indefinite delivery contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Sri International, a non-profit research and development institute. The $9.75 million IDC has a period of performance from September 12, 2023 to September 11, 2028 and is for toxicological evaluations of potential medications to support NIDA's mission. Under this IDC, Sri International has been awarded two task orders so far....
This Indefinite Delivery Contract (IDC) is a single-award contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Sri International, a non-profit research and development organization. The contract, valued at a ceiling of $342,897, is for the provision of IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES over a 5-year period of performance from September 27, 2021 to April 25, 2025. The contract was not set aside for any specific business size or socioeconomic...
The federal contract IDV award is for safety evaluation and toxicology studies and related services to support drug development efforts of the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The prime contractor, SRI International, a nonprofit research and development institute, will provide in vitro and in vivo exploratory and Investigational New Drug (IND)-directed toxicology studies for small molecule and biologic...
This federal contract indefinite delivery vehicle (IDV) award from the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) is a single-award contract with Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $5 million, 5-year IDV is for receptor binding and predictive toxicology services to support the agency's drug abuse research programs.
Under this IDV, two delivery orders have been issued to date. The first is a $300,609 firm-fixed-price task order for receptor profiling services from April 2024 to April 2025. The second is a $142,193 cost-plus-fixed-fee task order for receptor binding and predictive toxicology services from September 2023 to September 2024. Eurofins Panlabs has previously received over $30 million in federal prime contracts from agencies like the EPA, FDA, and VA for analytical testing, safety pharmacology, and other non-clinical research services. The original pre-solicitation notice indicated the contracted work would involve screening compounds for receptor binding activity, functional activity, and predictive toxicology to support drug discovery and development efforts.